Amid widespread vaccine hesitancy that could delay efforts to achieve the herd immunity required to end the COVID-19 pandemic, the top official from the Food and Drug Administration’s Center for Biologics Evaluation and Research—Peter Marks, MD, PhD—joined the AMA’s president for an in-depth webinar to answer physicians’ questions and explain how emergency use authorization (EUA) fits into the coronavirus vaccine-approval process.
Read more here : https://www.ama-assn.org/delivering-care/public-health/covid-19-vaccines-dive-deep-emergency-use-authorization?&utm_source=BulletinHealthCare&utm_medium=email&utm_term=120820&utm_content=NON-MEMBER&utm_campaign=article_alert-morning_rounds_daily&utm_uid=3407836&utm_effort=MRNRD0
Comentarios